Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.
about
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipientsProliferation signal inhibitor toxicities after thoracic transplantation.Comprehensive Review on Colorectal Cancer and Transplant.Smoking Status at Time of Listing for a Heart Transplant Predicts Mortality on the Waiting List: A Multicenter Prospective Observational Study.Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History.Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.
P2860
Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proliferation signal inhibitor ...... clinical management questions.
@en
Proliferation signal inhibitor ...... clinical management questions.
@nl
type
label
Proliferation signal inhibitor ...... clinical management questions.
@en
Proliferation signal inhibitor ...... clinical management questions.
@nl
prefLabel
Proliferation signal inhibitor ...... clinical management questions.
@en
Proliferation signal inhibitor ...... clinical management questions.
@nl
P2093
P2860
P1476
Proliferation signal inhibitor ...... clinical management questions.
@en
P2093
A Andreassen
A Zuckermann
F M Turazza
H Valantine
J Albanell
J F Delgado
P2860
P304
P356
10.1111/J.1399-0012.2011.01476.X
P577
2011-05-18T00:00:00Z